TP53 and familial pancreatic carcinoma: Further studies should be necessary to verify the functional significance of the interaction among RUNX2, ATF3, mutant p53 and TAp63 in the acquisition and/or maintenance of drug-resistant phenotype of pancreatic cancer cells.